Patent details

EP3634419 Title: DOSING REGIMEN COMPRISING A GONADOTROPIN-RELEASING HORMONE ANTAGONIST FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS

Basic Information

Publication number:
EP3634419
PCT Application Number:
EP2018064767
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP187319769
PCT Publication Number:
WO2018224497
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSING REGIMEN COMPRISING A GONADOTROPIN-RELEASING HORMONE ANTAGONIST FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS
French Title of Invention:
SCHÉMA POSOLOGIQUE COMPRENANT UN ANTAGONISTE DE L'HORMONE DE LIBERATION DE LA GONADOTROPINE POUR TRAITER DES FIBROMES UTÉRINS ET POUR RÉDUIRE LA PERTE EXCESSIVE DE SANG MENSTRUEL
German Title of Invention:
DOSIERUNGSREGIME ENTHALTEND EINEN GONADOTROPIN-FREISETZUNGS-HORMON ANTAGONISTEN ZUR BEHANDLUNG VON UTERINEN FIBROIDEN UND ZUR REDUZIERUNG VON MENSTRUELLEM BLUTVERLUST
SPC Number:

Dates

Filing date:
05/06/2018
Grant date:
29/01/2025
EP Publication Date:
15/04/2020
PCT Publication Date:
13/12/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
29/01/2025
EP B1 Publication Date:
29/01/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
05/06/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
22/01/2025
 
 

Name:
Kissei Pharmaceutical Co., Ltd.
Address:
19-48, Yoshino, Matsumoto-Shi, Nagano 399-8710, Japan (JP)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
03/03/2025
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
LOUMAYE, Ernest
Address:
Switzerland (CH)

2

Name:
POHL, Oliver
Address:
Switzerland (CH)

3

Name:
GOTTELAND, Jean-Pierre
Address:
Switzerland (CH)

Priority

Priority Number:
201762515232 P
Priority Date:
05/06/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61P 15/00;

Publication

European Patent Bulletin

Issue number:
202505
Publication date:
29/01/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
30/06/2025
Annual Fee Number:
8
Annual Fee Amount:
99 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
03/03/2025 Power Of Attorney 1
03/03/2025 Outgoing Correspondence 1